Source: Reuters

Critical Outcome Technologies: BRIEF-Critical Outcome Technologies Reports Q2 Loss Per Share Of C$0.11

* CRITICAL OUTCOME TECHNOLOGIES REPORTS FISCAL 2018 SECOND QUARTER FINANCIAL AND OPERATING RESULTS

Read full article »

Critical Outcome Technologies's Competitors | Critical Outcome Technologies's News | Critical Outcome Technologies's Financials

Followers on Owler

112

Annual Revenue

$5.0-25M

Employees

1-25

Alison Silva's photo - CEO of Critical Outcome Technologies

CEO

Alison Silva

CEO Approval Rating

70/100

Critical Outcome Technologies offers in silico drug discovery service to the pharmaceutical industry.